Phased Rollout of Bioequivalence Testing Requirement Suggested

Published: 2005-03-02 06:57:00

Updated: 2005-03-02 06:57:00

The Regulatory Reform Committee released on February 25th of its review details and recommendations on various amendment proposals to the Korea Pharmaceutical Affairs Law, covering the major areas such as bioequivalence testing and pharmaceutical small-unit packaging requirements.

On the propo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK